Table of Contents
What changed
Revenue rose 7.4% to NZ$265.5m and underlying EBITDA rose 3.2% to NZ$82.6m, a low-single-digit operating uplift. Reported NPAT more than doubled to NZ$31.5m from NZ$15.4m, but that growth is essentially a non-operating story given EBITDA moved only NZ$2.6m. Sales volumes were up 16.7%, with new sale volumes up 22.7% to 157 units. No final dividend was declared, versus a 1.3 cps prior-year payment. FY24 operating cash flow, capex and closing net debt were not disclosed in the supplied excerpts; undrawn headroom was NZ$88.5m at 31 March 2024, rising to circa NZ$100.0m by 23 May after NZ$21.0m of further sales proceeds.
What matters
- Operating progress is modest, not transformational. EBITDA growth of 3.2% on 7.4% revenue growth implies operating margin compression, and underlying EBITDA is a non-GAAP measure without a supplied bridge to statutory profit. The 104% NPAT jump should not be read as an operating signal.
- Second-half earnings reversed. HY24 NPAT was NZ$35.2m, so implied H2 NPAT was -NZ$3.7m (HY24 was 111.7% of the full-year figure). HY24 was only 45.6% of FY24 underlying EBITDA, so the shape at the operating line is less extreme than at the bottom line, pointing to H2 below-EBITDA items (revaluations, finance costs or tax) as the driver of the reversal.
- Capital returns are under pressure. The dividend has been cut to nil against a stated 30–50% of underlying EBIT policy. FY23 context is stark: OCF of NZ$70.2m against capex of NZ$164.0m produced pre-lease free cash flow of about -NZ$93.8m, and net debt of NZ$550.3m implied 6.9x FY23 EBITDA. The release discloses only headroom, not closing net debt, for FY24.
Expectations
No forward quantitative guidance, medium-term target or forward-work metric was supplied in the excerpts, so the release cannot be benchmarked to management targets. Against the HY24 shape, the full-year print confirms a second-half operating improvement (implied H2 EBITDA of NZ$45.0m versus HY24 NZ$37.6m) but a bottom-line deterioration. What the release does support is a volume recovery story (new sales +22.7%) and improving liquidity headroom; what it does not support is a return to dividends, a clear deleveraging trajectory, or margin expansion.
Quality of result
Quality is mixed. The EBITDA line grew slower than revenue, and the NPAT doubling is disproportionate to that operating move, suggesting material below-the-line help (likely fair-value movements on investment property, which is typical for retirement-village operators) rather than durable trading earnings. Total comprehensive income of NZ$70.5m sits well above NPAT, reinforcing the revaluation read. With FY24 OCF and capex not disclosed here, cash conversion cannot be verified; the prior-year OCF/EBITDA of 87.7% and deeply negative pre-lease FCF set a low bar, and the dividend suspension is consistent with cash constraints rather than a step-change in cash quality. ROE improved to 3.1% from 1.6% on roughly NZ$1.0b of equity, but remains low in absolute terms.
Unresolved
- What was FY24 operating cash flow, capex, and closing net debt, and where does net debt/EBITDA now sit against the prior 6.9x?
- What explains the -NZ$3.7m H2 NPAT — fair-value movements, finance costs, or a specific item — given H2 EBITDA rose sequentially?
- What is the bridge from statutory profit to the NZ$82.6m underlying EBITDA, and what has been excluded?
- Why was the dividend suspended outright rather than reduced, and what triggers a reinstatement under the 30–50% underlying EBIT policy?
- How durable is the 22.7% new-sales volume uplift given it drove only 7.4% revenue growth — is pricing or mix softening?
This briefing cannot assess FY24 cash conversion, leverage direction, or the statutory-to-underlying earnings reconciliation because those disclosures were not included in the supplied excerpts.
Key metrics
| Metric | FY24 | FY23 | Change |
|---|---|---|---|
| Revenue | $265.5m | $247.2m | +7.4% ↑ |
| EBITDA | $82.6m | $80.0m | +3.2% ↑ |
| Net profit after tax | $31.5m | $15.4m | +103.7% ↑ |
| Net cash inflow from operating activities | — | $70.2m | — |
| Declared dividend per share | — | 1.3c | — |
| Total assets | $0.0m | $2.5b | -100.0% ↓ |
Analytical metrics
| Metric | FY24 | FY23 | Context |
|---|---|---|---|
| Capex | — | $164.0m | — |
| Payout ratio vs NPAT | 0.0% | — | — |
| ROE (annualised) | 3.1% | 1.6% | Strengthening |
| HY24 share of FY24 revenue | 49.6% | — | Other half was 50.4% |
| HY24 share of FY24 EBITDA | 45.6% | — | Other half was 54.4% |
| HY24 share of FY24 NPAT | 111.7% | — | Other half was -11.7% |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.